Is Walgreens Boots Alliance, Inc. (WBA) Undervalued?
The traditional Graham Number cannot be calculated for Walgreens Boots Alliance, Inc. (WBA) due to missing data. Consider using DCF or other valuation methods for a complete picture.
Analysis updated March 6, 2026
WBA Key Valuation Metrics
| Metric | Value | Signal |
|---|---|---|
| Current Price | $11.98 | — |
| Graham Number | N/A | — |
| P/E Ratio | N/A | Unprofitable |
| P/B Ratio | 1.44 | ▲ Low |
| DCF Fair Value | N/A | — |
| Dividend Yield | 2.09% | — Moderate |
| 52-Week Range | $8.08 – $13.25 | Near 52-week high |
| Market Cap | N/A | Micro Cap |
| Sector | Healthcare | — |
How We Calculated WBA's Graham Number
The Graham Number, developed by Benjamin Graham (the father of value investing), estimates a stock's maximum fair price based on its earnings and book value.
Graham Number = √(22.5 × EPS × BVPS)
For Walgreens Boots Alliance, Inc. (WBA):
- Earnings Per Share (EPS): N/A
- Book Value Per Share (BVPS): N/A
WBA Dividend Profile
Walgreens Boots Alliance, Inc. currently pays a quarterly dividend of $0.06 per share, yielding 2.09% at the current price.
| Annual Dividend | $0.25 |
| Dividend Yield | 2.09% |
| Payout Ratio | N/A |
| Consecutive Years Paid | 5+ years |
| 5-Year Dividend Growth | -14.3% |
| Payment Frequency | Quarterly |
👑 Walgreens Boots Alliance, Inc. is a Dividend Aristocrat — it has increased its dividend for 25+ consecutive years.
Dividend History
WBA Value Score: 2/10
Our proprietary value score rates Walgreens Boots Alliance, Inc. a 2 out of 10, placing it in the “Overvalued / Caution” category for value investors.
Score Components
Graham Number not available
P/E not available
Trading near or below book value
DCF value not available
Solid 2.1% yield
Weak balance sheet metrics
Score methodology: How We Score Stocks
Stocks Similar to WBA
These Healthcare stocks have similar valuation profiles to Walgreens Boots Alliance, Inc.:
Frequently Asked Questions About WBA
Is WBA undervalued right now?
Based on Graham Number analysis, WBA does not appear significantly undervalued as of March 6, 2026. The Graham Number of $N/A compared to the current price of $11.98 indicates a N/A% difference.
What is Walgreens Boots Alliance, Inc.'s intrinsic value?
Using our DCF model, Walgreens Boots Alliance, Inc.'s estimated intrinsic value is $N/A per share. The Graham Number suggests a fair value of $N/A.
What is the Graham Number for WBA?
The Graham Number for WBA is $N/A, calculated using EPS of $N/A and Book Value Per Share of $N/A. The formula is sqrt(22.5 x EPS x BVPS).
Does WBA pay a dividend?
Yes, WBA pays dividends with a yield of 2.09%. The annual dividend is $0.25 per share. It has paid dividends for 5+ consecutive years.
Is WBA a good buy right now?
Our value score rates WBA a 2/10. The stock is in the "Overvalued / Caution" category. However, this is analysis — not financial advice. Consider your own risk tolerance, portfolio allocation, and investment timeline before making any decisions.
Start Analyzing WBA Today
Ready to invest in Walgreens Boots Alliance, Inc.? Open a free brokerage account and start trading WBA with $0 commissions.
We may earn a commission when you open an account through our links. This does not affect our analysis or ratings.
Learn More About Value Investing
Tools
- Graham Number Calculator — Calculate the Graham Number for any stock
- DCF Calculator — Run your own discounted cash flow analysis
- Stock Screener — Filter stocks by value metrics
Related Articles
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,96...
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial advice, a recommendation, or a solicitation to buy or sell any security. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions. Data sourced from Financial Modeling Prep API and may be delayed. Last updated: March 6, 2026.